NCT06058793 · Interventional trial
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
Overall registry status Completed
Phase 3
Conditions Liposarcoma, Dedifferentiated
Delaware Valley sites
- Abramson Cancer Center at Pennsylvania Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory